Markets:

Overview

News

Currencies

International

Treasuries

iRhythm Holdings, Inc. - Common Stock (NQ:IRTC)

111.82 -0.06 (-0.05%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iRhythm Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

February 06, 2025

From iRhythm

Via GlobeNewswire

iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference

January 13, 2025

From iRhythm

Via GlobeNewswire

iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

December 30, 2024

From iRhythm

Via GlobeNewswire

Critical Insights From iRhythm Technologies Analyst Ratings: What You Need To Know ↗

December 03, 2024

Via Benzinga

Forecasting The Future: 6 Analyst Projections For iRhythm Technologies ↗

October 31, 2024

Via Benzinga

Earnings Preview For iRhythm Technologies ↗

October 29, 2024

Via Benzinga

Top 3 Robotics and Automation Stocks for the Next AI Boom

December 13, 2024

The next wave of AI will include interactive and autonomous AI and these three companies are making inroads into these areas today

Via MarketBeat

Topics Artificial Intelligence

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗

December 02, 2024

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

Via Benzinga

iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference

November 20, 2024

From iRhythm

Via GlobeNewswire

Beyond The Numbers: 9 Analysts Discuss iRhythm Technologies Stock ↗

October 14, 2024

Via Benzinga

Key Takeaways From iRhythm Technologies Analyst Ratings ↗

September 25, 2024

Via Benzinga

iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring

November 18, 2024

Five new studies span three focus areas for LTCM devices: digital engagement and patient satisfaction, arrhythmia patterns during sleep and activity, and the potential health care resource and economic...

From iRhythm

Via GlobeNewswire

iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference

November 05, 2024

From iRhythm

Via GlobeNewswire

IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

November 01, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device

October 30, 2024

From iRhythm

Via GlobeNewswire

iRhythm Technologies Announces Third Quarter 2024 Financial Results

October 30, 2024

From iRhythm

Via GlobeNewswire

Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy

October 28, 2024

From iRhythm

Via GlobeNewswire

Trump Media & Tech, ImmunityBio, And iRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio? ↗

October 27, 2024

These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?

Via Benzinga

Topics Government

IRHYTHM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc. - IRTC

October 25, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Nasdaq Turns Higher; Verizon Shares Fall After Q3 Results ↗

October 22, 2024

Via Benzinga

With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says ↗

October 22, 2024

FDA approves iRhythm's 510(k) submission for Zio AT device. A second approval may come soon, enhancing the company's mobile cardiac telemetry services.

Via Benzinga

Crude Oil Rises Sharply; 3M Posts Upbeat Earnings ↗

October 22, 2024

Via Benzinga

Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday ↗

October 22, 2024

Via Benzinga

Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗

October 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 21, 2024

Via Benzinga

iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device

October 21, 2024

Zio AT device, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) monitoring service for non-critical care patients

From iRhythm

Via GlobeNewswire

iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024

October 16, 2024

From iRhythm

Via GlobeNewswire

IRHYTHM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc. - IRTC

September 30, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence

September 11, 2024

From iRhythm

Via GlobeNewswire

iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting

September 09, 2024

From iRhythm

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.